Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer
“[…] results of Tolmeijer et al. show the promise of on-treatment ctDNA detection as early read out for treatment response to potentially help guide treatment management of patients with mCRPC.” Credit: 2024 Tolmeijer et al. “[…] results of Tolmeijer et al. show the promise of